Scripps Research gives old anti-malaria drug better staying power

San Diego Union Tribune

Center

Factuality

Ownership

Scripps Research gives old anti-malaria drug better staying power

A new clinical trial from Scripps Research hopes to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer. Working with a contract drug manufacturing and testing firm in the United Kingdom, 25 to 30 healthy volunteers are now starting to receive the first doses of a new drug that is a long-acting enhancement of atovaquone, part of Malarone, the once-daily malaria-prevention m…